← Back to Search

Olympus VE2 NIR Imaging System for Lung Cancer

Phase 1 & 2
Recruiting
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
-Subject has a suspicious lung lesion for which a minimally invasive segmentectomy is planned -OR- sub-ject has an esophageal lesion for which an esophagectomy is planned -
Subject is 18 years of age or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during surgery
Awards & highlights

Study Summary

This trial will assess whether NIR imaging can help doctors identify and assess perfusion of the gastric conduit and segmental anatomy during minimally invasive esophagectomy and pulmonary segmentectomy.

Eligible Conditions
  • Lung Cancer
  • Esophageal Lesion

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and during surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
To utilize NIR intraoperative imaging with the Olympus VE2 NIR Imaging System for esophagectomy patients.
To utilize NIR intraoperative imaging with the Olympus VE2 NIR Imaging System for segmentectomy patients.

Trial Design

2Treatment groups
Experimental Treatment
Group I: During Minimally Invasive Pulmonary Segmentectomy (Group 2)Experimental Treatment2 Interventions
Group II: During Minimally Invasive Esophagectomy (Group 1)Experimental Treatment2 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Indocyanine green
FDA approved

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,918 Previous Clinical Trials
13,192,790 Total Patients Enrolled
OlympusIndustry Sponsor
18 Previous Clinical Trials
3,230 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the aggregate number of individuals participating in this trial?

"Affirmative. Information located on clinicaltrials.gov verifies that recruiting for this study is still ongoing, with an initial post date of October 29th 2020 and a recent update to the listing in April 2022. 45 patients are being sought out at 1 medical centre."

Answered by AI

Is recruitment currently in progress for this experiment?

"Affirmative, the trial is still open for recruitment. It was initially posted on October 29th 2020 and last edited on April 20th 2022. The research team seeks 45 participants from a single site."

Answered by AI
~10 spots leftby Mar 2025